Individualized Approach vs. Fixed Approach

Inclusion Criteria: * Age ≥18 years * The patient understands the nature of the study, treatment procedure and provides written informed consent * Symptomatic paroxysmal atrial fibrillation as defined by the current guidelines * Willing to comply with specified pre-, post- and follow-up testing, evaluations and requirements * Expected to remain available (geographically stable) for at least 12 months after enrollment Exclusion Criteria: * Atrial fibrillation secondary to a reversible cause or of non-cardiac origin * Previous AF ablation procedure * Longstanding persistent AF * Documented left atrial thrombus on imaging (e.g., transesophageal echocardiogram, angiogram) * NYHA functional Class IV heart failure * Unstable angina * Left ventricular ejection fraction \< 30% * Valvular disease requiring interventional treatment * Cardiac surgery within 3 months prior to enrolment * Left atrial size \> 55 mm as measured in the parasternal antero-posterior view * Uncontrolled bleeding, diathesis, coagulopathy or pro-coagulant state * Active systemic infection or sepsis * Other co-morbid condition(s) that could limit the participant's ability to participate in the study or to comply with follow-up requirements, or impact the scientific integrity of the study.